Publications

Publications keep interested parties informed about the latest scientific, clinical, trial-based, and peer-reviewed documentation about our products and pipeline. Find the latest below:

sort by:

Diabetes Technol

2018; 20(10): 639-647

Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.

view publication

CPT Pharmacometrics Syst. Pharmacol

2017; 6: 365-72

A Population Dose-Response Model for Inhaled Technosphere Insulin Administered to Healthy Subjects.

view publication

J. Diabetes Sci. Technol.

2017; 11(1): 157–159

The Need for Faster Insulin: Problem Solved?

view publication

J. Diabetes Sci. Technol

2017; 11(1): 148–156

Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.

view publication

BMJ Open Diabetes Res. Care

2016; 4: e000228

Impact of symptomatic upper respiratory tract infections on insulin absorption and action of Technosphere inhaled Insulin

view publication

Drugs Real World Outcomes

2016; 3: 191-99

The Clinical and Economic Impact of the V-Go® Disposable Insulin Delivery Device for Insulin Delivery in Patients with Poorly Controlled Diabetes at High Risk

view publication

Endocr Pract.

2016; 22(6): 726-35

Clinical and Cost-Effectiveness of Insulin Delivery with V-Go® Disposable Insulin Delivery Device Versus Multiple Daily Injections in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin

view publication

Diabetes Technol. Ther

2016; 18(9): 574–585

Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

view publication

J Diabetes Sci Technol.

2015; 9(5): 1111-16

V-Go Insulin Delivery System versus Multiple Daily Insulin Injections for Patients with Uncontrolled Type 2 Diabetes Mellitus

view publication

Diabetes Ther.

2015; 6(4): 531-45

Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System

view publication

Diabetes Care

2015; 38(12): 2274-81

Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naïve Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents.

view publication

Diabetes Care

2015; 38(12): 2266-73

Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.

view publication
sort by:
<